| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Funder | Competition | Research | Implementation/Clinical Care | KX/ Travel | Education | Open to projects outside of Canada? | Lead must be based in Canada? | Key words | Due date | Max value | Currency | Length (months) | Website | ||||||||||||
2 | Gates Foundation | Innovations in Decentralized Pan-Orthoebolavirus Diagnostics | Y | Y | N | N | Y | N | Seeks specific, field-ready innovations in pan-Orthoebolavirus diagnostics that address the concrete gaps exposed by the 2026 outbreak and prepare the global community for the next one. Proposals should come from teams with demonstrated track records in Orthoebolaviruses or related high-consequence pathogen diagnostics. | July 31, 2026 | 150,000 - 800,000 | USD | 18 - 36 | https://gcgh.grandchallenges.org/challenge/innovations-decentralized-pan-orthoebolavirus-diagnostics | ||||||||||||
3 | NIH | Global Infectious Disease Research Training (GID) | Y | Y | N | Y | Y | Y | Open to US institutions with LMIC partner or to LMIC institutions. Application should propose a collaborative training program that will strengthen the capacity of a LMIC institution to conduct infectious disease research (not including HIV/AIDS). | August 6, 2026 | 230,000 | USD | 60 | https://grants.nih.gov/grants/guide/pa-files/PAR-24-174.html | ||||||||||||
4 | Grand Challenges Canada | Climate and Health Innovation: Africa, Latin America, and the Caribbean | Y | Y | N | N | Y | N | Funds solutions that enable local health actors to turn climate- driven health risk signals into timely health service delivery action, reducing health harms from mosquito-borne infections, extreme heat, and poor air quality. Must be Transition to Scale innovations, meaning approaches that have already been tested, proven to be effective, and are now ready to be implemented more widely. Innovations must be implemented in Africa, Latin America or the Carribean. | August 12, 2026 | 250,000 - 2,000,000 | USD | 24 | https://www.grandchallenges.ca/funding-opportunity-nexa/ | ||||||||||||
5 | TDR & PAHO | 2026–2027 Joint PAHO/TDR Impact Grants for Regional Priorities | Y | Y | N | N | Y | N | This call aims to contribute to the generation of evidence to fill gaps in priority research areas that will guide the development and implementation of public health policies, interventions and services. Focus for this call will be on the following group of diseases and/or health conditions: tuberculosis, other opportunistic infections associated with advanced HIV disease, and the emerging use of AI-driven approaches for these diseases. Research proposed must be conducted in LMIC countries in the Latin America and Caribbean Region. PI must be based in an institution in a LAC country or territory. | August 19, 2026 | 30,000 | USD | 12 - 18 | https://who.my.site.com/etdr/s/gs-solicitation/a0pVj000007VRhRIAW/ca260032 | ||||||||||||
6 | Coefficient Giving | Global Health and Wellbeing in an Era of Transformative AI | Y | Y | Y | Y | Y | N | Open to individuals and instititions globally. Supports research, policy development, implementation, and field-building to help ensure AI improves human health and wellbeing, with particular attention to risks for and benefits to the global poor. Particularly interested in funding new organizations and supporting direct implementation. | August 21, 2026 | <100,000 - >1,000,000 | USD | 12 - 18 | https://coefficientgiving.org/funds/global-health-wellbeing-opportunities/request-for-proposals-global-health-and-wellbeing-in-an-era-of-transformative-ai/#3-how-to-apply | ||||||||||||
7 | IDRC | Addressing Neglected Areas of Sexual and Reproductive Health and Rights in sub-Saharan Africa | Y | Y | N | N | Y | N | Funds Implementation Research Teams working to improve neglected sexual and reproductive health and rights (SRHR) for underserved populations across sub-Saharan Africa. Proposed research project must take place in at least one eligible country in sub-Saharan Africa. | August 23, 2026 | 1,200,000 | CAD | https://idrc-crdi.ca/en/funding/upcoming-funding-opportunity-addressing-neglected-areas-sexual-and-reproductive-health-and?utm_source=Funding+Alerts&utm_campaign=8f90ee9da2-EMAIL_CAMPAIGN_7_31_2020_9_57_COPY_01&utm_medium=email&utm_term=0_02f2dae0ce-8f90ee9da2-481119737 | |||||||||||||
8 | Gates Foundation | AI-Enabled Consumer Engagement to Advance Family Planning | Y | Y | N | N | Y | N | This RFP seeks to answer a core question for the family planning field: can AI-enabled direct-to-consumer engagement improve contraceptive uptake, continuation, and informed method choice at scale - and, if so, which approach works best? The challenge will focus on women and girls of reproductive age in sub-Saharan Africa. Interventions can be delivered through public sector platforms, private sector channels, or hybrid models. | August 25, 2026 | 500,000 | USD | 12 | https://gcgh.grandchallenges.org/challenge/ai-enabled-consumer-engagement-advance-family-planning | ||||||||||||
9 | Horizon Europe - EDCTP3 | Enhancing integrated research and healthcare in sub-Saharan Africa through digital innovation and Artificial Intelligence | Y | Y | N | N | Y | N | Should contribute to strengthening clinical human capital base in R&I, enhancing talent retention, knowledge sharing of best practices within the research and innovation landscape, accelerate integration of digital tools into health systems, expand and scale up validated innovations with tangible implementation at national and/or sub-regional levels. | September 2, 2026 | 15,000,000 - 18,000,000 | EUR | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-JU-GH-EDCTP3-2026-03-DIGIT-02?keywords=HORIZON-JU-GH-EDCTP3-2026&isExactMatch=true&status=31094501,31094502,31094503&order=DESC&pageNumber=1&pageSize=50&sortBy=startDate | |||||||||||||
10 | Gates Foundation | Multiplex Platforms to Assess Indicators of Micronutrient Status, Inflammation and Infectious Disease | Y | N | N | N | Y | N | This Grand Challenge seeks novel approaches to extend analytical coverage, improve sensitivity and specificity, simplify measurement, reduce cost, and enable frequent monitoring of micronutrient status by local institutions. Open to nonprofit organizations, for-profit companies, international organizations, government agencies and academic institutions. | September 8, 2026 | 200,000 - 800,000 | USD | 12 - 24 | https://gcgh.grandchallenges.org/challenge/multiplex-platforms-assess-indicators-micronutrient-status-and-infection-and-inflammation | ||||||||||||
11 | Science Granting Councils Initiative in sub-Saharan Africa (SGCI) | Supporting STISA 2034: SGCI Multilateral Research Call advancing Africa’s Science, Technology and Innovation priorities | Y | N | N | N | Y | N | Funds collaborative, multi-country research projects that advance Africa’s science, technology and innovation priorities and contribute to sustainable development outcomes across the continent. The call supports research aligned with five thematic streams: Agriculture, Health, Artificial intelligence and Digital technologies, Energy, Environment. Applications must be submitted by a consortium consisting of one lead applicant organization and two to four co-applicant organizations from participating SGCI countries. | September 25, 2026 | 50,000 - 300,000 per consortium member | CAD | 36 | https://idrc-crdi.ca/en/funding/supporting-stisa-2034-sgci-multilateral-research-call-advancing-africas-science-technology?utm_source=Funding+Alerts&utm_campaign=9d4dd71633-EMAIL_CAMPAIGN_7_31_2020_9_57_COPY_01&utm_medium=email&utm_term=0_02f2dae0ce-9d4dd71633-481119737 | ||||||||||||
12 | CEPI | Innovations to Prepare for Future Epidemics and Pandemics | Y | N | N | N | Y | N | For (1) innovative vaccine platforms that can transform outbreak response to Disease X, addressing needs for speed, safety/efficacy, and access; or (2) advance new vaccine candidates for CEPI priority pathogens and viral families. | Rolling until 2026 | 5,000,000 | USD | 36 - 60 | https://cepi.net/calls-for-proposals?selectedProposal=9bde4615-b7b1-5f00-a079-a3080e88a845&selectedProposal=c08cff7c-f002-506a-8afb-cc2e921056ae | ||||||||||||
13 | Health Research BC | Match Funding | Y | N | N | N | N | Y | Applying to peer-reviewed, non-BC-government-funded research competition that requires match funding; Link to human health; Must be used in BC | 5 weeks before competition deadline | https://healthresearchbc.ca/match-funding/ | |||||||||||||||
14 | Addax & Oryx Foundation | N/A | N | Y | N | N | Y | N | Low success rate (1%); Root causes of poverty; Africa and Middle East; Non-profit/NGO-led; Local community involvement; Holistic (Health, education, community development, environment) | Rolling | https://addax-oryx-foundation.org/en/submit-a-project | |||||||||||||||
15 | Humanitarian Grand Challenge | Transition to Scale | Y | N | N | N | Y | N | Humanitarian crises; Health supplies and equipment; WASH; Access to data; Energy | Rolling | 3,000,000 | CAD | https://www.grandchallenges.ca/funding-opportunities/ | |||||||||||||
16 | Grand Challenges Canada | Transition to Scale | Y | Y | N | N | Y | N | Scaling innovations in Maternal and Newborn Health, Digital Health, Medical Products and Technology, Community Health Worker Models, Urban Sanitation & Hygiene, and Options for safe pregnancy termination; Requires match-funding' SSA-led | Rolling | 3,000,000 | CAD | https://www.grandchallenges.ca/funding-opportunities/ | |||||||||||||
17 | Roncalli International Foundation | Grant | N | Y | N | Y | Y | Y | Requires Canadian organization to receive funds, but partnership with implementing community | Rolling | 35,000 | CAD | 12 | https://roncalli.ca/en/grant-application/eligibility-criteria/ | ||||||||||||
18 | Nestle Foundation | Pilot Grants | Y | N | N | Y | Y | N | LMIC-based; Clinical research in nutrition; Public health relevance; Potetential for implementation; Nutrition education/health promotion | Rolling | 20,000 | USD | 24 | https://www.nestlefoundation.org/apply.html | ||||||||||||
19 | Nestle Foundation | Small Research Grants | Y | N | N | Y | Y | N | LMIC-based; Usually after Pilot Grant; Clinical research in nutrition; Public health relevance; Potetential for implementation; Nutrition education/health promotion | Rolling | 50,000 | USD | 24 | https://www.nestlefoundation.org/apply.html | ||||||||||||
20 | Nestle Foundation | Large Research Grants | Y | N | N | Y | Y | N | LMIC-based; Usually after Pilot Grant; Clinical research in nutrition; Public health relevance; Potetential for implementation; Nutrition education/health promotion | Rolling | 300,000 | USD | 36 | https://www.nestlefoundation.org/apply.html | ||||||||||||
21 | Nestle Foundation | Training Grant | Y | N | N | Y | Y | N | MSc or PhD Student; LMIC-based; Clinical research in nutrition; Public health relevance; Potetential for implementation; Nutrition education/health promotion | Rolling | 20,000 | USD | 24 | https://www.nestlefoundation.org/apply.html | ||||||||||||
22 | Nestle Foundation | Re-entry Grants | Y | N | N | N | Y | N | LMIC-based; Supports return to home country; Needs support from host institution | Rolling | 50,000 | USD | 36 | https://www.nestlefoundation.org/apply.html | ||||||||||||
23 | Commonweath Fund | Project Grants | Y | Y | N | N | Y | N | Primarily US-focused; Global priorities include: models of effective primary care, policy solutions to improve health care affordability , and partners with access to data sets to complete international comparisons of access, cost, and quality of care. Clinical, policy, or implementation research | Rolling | 180,000 | USD | 12 | https://www.commonwealthfund.org/grants | ||||||||||||
24 | Fonds d'Innovation pour le Developpement | Preperation Grant | Y | N | N | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; aims to pilot, test and evaluate the impact of projects using rigorous scientific methods; For preparing for pilot or preperation for scaling grant | Rolling | 50,000 | EUR | 6 | https://fundinnovation.dev/en/launch-project | ||||||||||||
25 | Fonds d'Innovation pour le Developpement | Pilot Grant | Y | N | N | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; Testing innovations in real-world environment | Rolling | 200,000 | EUR | 24 | https://fundinnovation.dev/en/launch-project | ||||||||||||
26 | Fonds d'Innovation pour le Developpement | Test and Preparation for Scaling Up | Y | N | N | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; ; Testing for impact on larger scale and evaluating cost-effectiveness | Rolling | 1,500,000 | EUR | 36 | https://fundinnovation.dev/en/launch-project | ||||||||||||
27 | Fonds d'Innovation pour le Developpement | Scaling Up | Y | N | Y | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; aims to pilot, test and evaluate the impact of projects using rigorous scientific methods; Implementation following rigorous evidence of impact and cost-effectiveness | Rolling | 4,000,000 | EUR | 36 | https://fundinnovation.dev/en/launch-project | ||||||||||||
28 | Fonds d'Innovation pour le Developpement | Transformatiom of Public Policies | N | N | Y | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; Institutionalizing innovations or building capacity of governements to design, test, and evalution innovations | Rolling | 500,000 | EUR | 24 | https://fundinnovation.dev/en/launch-project | ||||||||||||
29 | Founders Pledge | Global Health and Development Fund | N | Y | N | N | Y | N | Implementation, not research. Global health and development programs, especially programs that can, in expectation, save a life for under $4,000, avert a DALY for under $70, or double income for one person at a cost of less than $30. Note that this includes interventions that affect economic growth. We don’t necessarily require that grantees be able to point to an RCT in order to demonstrate cost-effectiveness | Rolling | 300,000 | USD | https://www.founderspledge.com/requests-for-funding | |||||||||||||
30 | Open Philanthropy | Grants - Global Health and Wellbeing: Scientific Research | Y | N | N | N | Y | N | Current topics of interest include road-spectrum antiviral drugs, vaccine development, basic immunology, some aspects of cardiovascular disease, Alzheimer’s disease, predicting mouse-to-human translation, control of inflammation, epigenetics, novel scientific tools and methods, malaria, and research on how biomedical research may be improved. | Rolling | 50,000 - 2,600,000 | USD | https://www.openphilanthropy.org/focus/scientific-research/ | |||||||||||||
31 | ||||||||||||||||||||||||||
32 | ||||||||||||||||||||||||||
33 | ||||||||||||||||||||||||||
34 | ||||||||||||||||||||||||||
35 | ||||||||||||||||||||||||||
36 | ||||||||||||||||||||||||||
37 | ||||||||||||||||||||||||||
38 | ||||||||||||||||||||||||||
39 | ||||||||||||||||||||||||||
40 | ||||||||||||||||||||||||||
41 | ||||||||||||||||||||||||||
42 | ||||||||||||||||||||||||||
43 | ||||||||||||||||||||||||||
44 | ||||||||||||||||||||||||||
45 | ||||||||||||||||||||||||||
46 | ||||||||||||||||||||||||||
47 | ||||||||||||||||||||||||||
48 | ||||||||||||||||||||||||||
49 | ||||||||||||||||||||||||||
50 | ||||||||||||||||||||||||||
51 | ||||||||||||||||||||||||||
52 | ||||||||||||||||||||||||||
53 | ||||||||||||||||||||||||||
54 | ||||||||||||||||||||||||||
55 | ||||||||||||||||||||||||||
56 | ||||||||||||||||||||||||||
57 | ||||||||||||||||||||||||||
58 | ||||||||||||||||||||||||||
59 | ||||||||||||||||||||||||||
60 | ||||||||||||||||||||||||||
61 | ||||||||||||||||||||||||||
62 | ||||||||||||||||||||||||||
63 | ||||||||||||||||||||||||||
64 | ||||||||||||||||||||||||||
65 | ||||||||||||||||||||||||||
66 | ||||||||||||||||||||||||||
67 | ||||||||||||||||||||||||||
68 | ||||||||||||||||||||||||||
69 | ||||||||||||||||||||||||||
70 | ||||||||||||||||||||||||||
71 | ||||||||||||||||||||||||||
72 | ||||||||||||||||||||||||||
73 | ||||||||||||||||||||||||||
74 | ||||||||||||||||||||||||||
75 | ||||||||||||||||||||||||||
76 | ||||||||||||||||||||||||||
77 | ||||||||||||||||||||||||||
78 | ||||||||||||||||||||||||||
79 | ||||||||||||||||||||||||||
80 | ||||||||||||||||||||||||||
81 | ||||||||||||||||||||||||||
82 | ||||||||||||||||||||||||||
83 | ||||||||||||||||||||||||||
84 | ||||||||||||||||||||||||||
85 | ||||||||||||||||||||||||||
86 | ||||||||||||||||||||||||||
87 | ||||||||||||||||||||||||||
88 | ||||||||||||||||||||||||||
89 | ||||||||||||||||||||||||||
90 | ||||||||||||||||||||||||||
91 | ||||||||||||||||||||||||||
92 | ||||||||||||||||||||||||||
93 | ||||||||||||||||||||||||||
94 | ||||||||||||||||||||||||||
95 | ||||||||||||||||||||||||||
96 | ||||||||||||||||||||||||||
97 | ||||||||||||||||||||||||||
98 | ||||||||||||||||||||||||||
99 | ||||||||||||||||||||||||||
100 |